The product has been developed by US Finch Therapeutics Co., and Takeda has obtained a global exclusive license. Applications are in ulcerative colitis and other diseases.
Takeda news release, April 6, 2017
The product has been developed by US Finch Therapeutics Co., and Takeda has obtained a global exclusive license. Applications are in ulcerative colitis and other diseases.
Takeda news release, April 6, 2017